Gene Query: MAP3K13

Dataset Description Geneva Score
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 55.12
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 55.12
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 20.5
Effect of CHKA knockdown on C4-2 cell transcriptome 18.27
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 17.92
SRSF2 mutations impair hematopoiesis and alter exon recognition 16.43
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 16.41
The regulartory role of ZCCHC24 in splicing machinery 14.83
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 13.05
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 12.19
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 11.5
HNF1 regulates critical functions of the human epididymis epithelium. 11.5
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 11.39
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 11.36
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 11.36
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 10.9
Generating Patterned Kidney Organoids for Studying Development and Diseases 10.86
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 10.82
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 10.56
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 10.54
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 10.45
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 10.42
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 10.39
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 10.35
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 10.21
RNA sequencing of matched nephrectomy samples [RNA-seq] 10.21
Active translatome profiling with RiboLace in MCF7 cells 10.1
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 10.0
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 9.55
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 9.55
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 9.5
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 9.26
Targeting EZH2 in MYCN-amplified Neuroblastoma 9.26
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 9.24
Paxillin regulates genomic networks in prostate cancer [LNCaP] 9.23
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 9.22
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 9.19
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 9.11
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 9.08
HNF1A deficiency impairs β-cell fate, granule maturation and function 9.06
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 8.91
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 8.83
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 8.78
The comparison of high-throughput single-cell RNA-seq methods 8.59
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 8.33
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 7.98
Generation and functional characterization of MDSC-like cells 7.86
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 7.84
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 7.67
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 7.46
Effect of BMP inhibition or stimulation of primary human keratinocytes 7.36
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 7.36
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 7.3
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 7.25
RNA expression following TMPRSS11B overexpression or depletion 7.08
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 7.04
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 7.03
Transcriptome analysis of H9 hESC derived cerebral organoids 7.03
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 6.97
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 6.93
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 6.91
Comparing gene expression in iPSC derived RPE from control and AMD donors 6.89
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 6.83
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 6.82
Androgen Receptor-regulated genes in prostate cancer cells 6.82
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 6.8
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 6.78
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 6.72
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 6.7
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 6.64
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 6.64
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 6.59
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 6.23
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 6.23
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 6.19
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 6.19
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 6.19
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 6.18
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 6.14
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 6.11
DRB/GRO-Seq -/+ UV 6.01
Non-coding regions are the main source of tumor-specific antigens 5.97
Non-coding regions are the main source of tumor-specific antigens [human] 5.97
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 5.87
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 5.87
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 5.84
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 5.78
A transcriptome dataset revealing the molecular features of breast cancer stem cells 5.77
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 5.77
Effect of disulfiram treatment on pediatric high grade glioma 5.72
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 5.64
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 5.64
Global response to chemotherapy-induced apoptosis 5.62
Identification of renal resident macrophages across species 5.6
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 5.58
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 5.56
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 5.56
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 5.52
Direct Isolation and Characterization of Human Nephron Progenitors. 5.5
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 5.48
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 5.46
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 5.45
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 5.43
Functional role of SLIT2 and ROBO1 in trophoblasts 5.36
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 5.34
scRNASeq analysis of cycling cardiomyocytes 5.3
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 5.23
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 5.22
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 5.22
Alagille_Nodder 5.19
RNA Seq of Alagille liver biopsies 5.19
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 5.18
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 5.16
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 5.14
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 5.13
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 5.13
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 5.13
HEK293 TFAM Knockout Expression Study 5.04
RNA-Seq with and without RNase treatment in PCa cell lines 4.93
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 4.93
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 4.9
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 4.82
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 4.78
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 4.76
RNA-seq of IL-4 stimulated human keratinocytes 4.69
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 4.67
Tracing Enhancer Networks using Epigenetic Traits (TENET) 4.65
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 4.64
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 4.62
The landscape of alternative splicing in aggressive prostate cancers 4.62
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 4.61
IRF2 is a master regulator of human keratinocyte stem cell fate 4.61
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 4.6
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 4.57
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 4.55
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 4.51
RNA-sequencing 4.46
STX4 Over-Expression in Human islets 4.45
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 4.42
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 4.37
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 4.32
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 4.31
CROP-Seq in Primary Human T Cells 4.31
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 4.31
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 4.29
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 4.29
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 4.28
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 4.28
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 4.19
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 4.17
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 4.17
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 4.13
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 4.12
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 4.08
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 4.07
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 4.05
Tpl-2 small molecule project 4.04
Tpl-2 and MEK small molecule inhibitors 4.04
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 4.03
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 4.02
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 3.98
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 3.96
Identification of transcription start sites for human A549 cell line using ReCappable-seq 3.95
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 3.93
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 3.9
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 3.9
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 3.85
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 3.82
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 3.71
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 3.71
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 3.71
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 3.67
HNRNPL and its RNA Targets in Prostate Cancer 3.64
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 3.64
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 3.62
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 3.61
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 3.58
Activity-dependent transcriptional changes in human neurons 3.58
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 3.55
Reprogrammed myeloid cell transcriptomes in NSCLC 3.51
WRN knockout effects upon gene expression in SW48 and OVK18 3.51
Regulation of Lipids is Central to Replicative Senescence 3.51
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 3.5
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 3.49
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 3.49
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 3.49
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 3.49
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 3.48
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 3.48
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 3.44
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 3.39
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 3.39
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 3.37
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 3.37
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 3.36
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 3.34
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 3.34
The gene expression profiles of gallbladder cancer 3.34
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 3.33
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 3.33
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 3.32
Identification of Atrial Fibrillation associated genes and functional non-coding variants 3.29
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 3.29
TT-Seq captures the human transient transcriptome 3.29
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 3.28
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 3.28
RNA-seq of Single-Cell Genotyping of Transcriptomes 3.28
Single-Cell Genotyping of Transcriptomes 3.28
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 3.27
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 3.24
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 3.23
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 3.22
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 3.2
Transcriptome of diurnal human blood neutrophils 3.19
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 3.18
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 3.18
4sUDRB-seq: measuring transcription elongation and initiation genomewide 3.17
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 3.17
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 3.14
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 3.14
Effect of PBK knockdown on C4-2 cell transcriptome 3.14
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 3.12
LINE-2 transposable elements are a source of functional human microRNAs and target sites 3.11
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 3.1
hnRNP C is a key regulator of protein synthesis in mitosis 3.1
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 3.07
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 3.07
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 3.07
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 3.07
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 3.04
RNA-seq of naive and primed ES cells (NHSM) 3.04
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 3.03
Role for citron kinase in prostate cancer growth 3.01
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 2.97
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 2.97
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 2.96
Common inflammatory pathways between NEC and Crohn's disease 2.94
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 2.93
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 2.93
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 2.93
single cell RNA-seq from GM12878 (ENCSR673UIY) 2.93
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 2.92
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 2.92
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 2.91
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 2.9
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 2.9
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 2.84
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 2.83
Recovery and analysis of nascent RNA 2.83
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 2.81
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 2.78
HNRNPM-regulated splicing dependencies in prostate cancer 2.77
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 2.77
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 2.77
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 2.73
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 2.73
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 2.73
The cytokine environment influence on human skin-derived T cells 2.72
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 2.71
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 2.67
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 2.65
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 2.65
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 2.62
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 2.61
Capturing the Interactome of Newly Transcribed RNA (RICK) 2.56
Capturing the Interactome of Newly Transcribed RNA 2.56
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 2.55
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 2.54
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 2.54
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 2.54
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 2.54
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 2.54
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 2.52
Effect of nuclear IL-33 on gene expression 2.51
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 2.5
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 2.48
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 2.47
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 2.46
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 2.43
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 2.42
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 2.37
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 2.37
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 2.33
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 2.31
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 2.31
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 2.28
Human neutrophil genome during PMA- and E. coli encounter-induced activation 2.28
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 2.27
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 2.25
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 2.23
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 2.23
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 2.23
Gene expression profile of multiple myeloma cell lines treated with CB-5083 2.23
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 2.2
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 2.2
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 2.2
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 2.19
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 2.19
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 2.19
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.18
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 2.17
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 2.14
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 2.13
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 2.11
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 2.08
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 2.08
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 2.07
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 2.07
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 2.07
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 2.06
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 2.06
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 2.06
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 2.03
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 2.02
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 2.01
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 1.96
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 1.95
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 1.95
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 1.94
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 1.91
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 1.89
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 1.87
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.84
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 1.84
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 1.83
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 1.8
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 1.79
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 1.79
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 1.79
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 1.78
Zone dependent distinctive gene expression profile of the normal human liver tissue 1.75
Mapping interactions for the TNIP2 hub protein 1.73
MicroRNA-125a-5p overexpression in human macrophages 1.7
Single-cell analysis of human kidney organoids 1.67
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 1.66
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.63
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.62
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 1.62
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 1.62
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.61
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.61
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 1.59
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 1.55
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 1.55
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 1.5
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 1.5
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 1.49
LIN28A modulates splicing and gene expression programs in breast cancer cells 1.49
Energy Metabolism during Anchorage-Independence 1.49
Role of cervicovaginal microbiota in genital inflammation 1.45
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 1.44
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 1.42
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 1.4
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 1.4
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.37
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.36
RNAseq in Alzheimer's Disease patients 1.34
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 1.33
Transcriptome profiling of 5 human adenocarcinoma cell lines 1.32
The pause-initiation limit restricts transcription activation in human cells 1.32
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 1.31
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 1.31
Dermal endothelial cells of type 2 diabetic patients 1.27
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 1.27
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 1.24
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 1.2
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 1.2
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 1.2
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 1.18
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 1.18
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 1.18
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 1.16
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 1.16
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 1.16
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 1.16
Genome-wide mapping of TEL-AML1 targets in acute leukemia 1.15
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 1.11
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 1.09
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 1.09
RNA-Seq from human ILC transitional populations 1.09
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 1.09
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 1.08
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 1.07
FGF2 regulation of gene expression in stable inducible Neurons 1.03
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 1.02
Investigate A2M treatment on human prostate cancer xenograft in mice 1.01
Investigate A2M treatment on human prostate cancer and mouse liver 1.01
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 0.92
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 0.92
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.92
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 0.91
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.91
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 0.91
FOXP1 orchestration of ASD-relevant signaling pathways. 0.9
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 0.9
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.89
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.89
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.89
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.88
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.87
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.87
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 0.87
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 0.86
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 0.84
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 0.84
Transcriptional profiling of microglia; current state of the art and future perspectives 0.83
Human ovarian granulosa cell transcriptome 0.81
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.81
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.78
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.78
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 0.78
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 0.77
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 0.77
ML29755 RNA-seq data 0.77
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.73
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.73
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.71
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.71
RNA sequencing of human pancreatic cancer cell lines 0.7
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.68
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.68
Identification of expressed and conserved human non-coding RNAs 0.67
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.67
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.67
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 0.65
Regulation of highly expressed hCINAP on translatome 0.64
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.63
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.61
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.61
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.59
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.58
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.58
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.57
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.57
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 0.57
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.56
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 0.51
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 0.49
RNA-Seq in PWS iPSC-derived neurons 0.48
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 0.47
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.46
Electronic cigarettes 0.45
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 0.45
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.44
Interphase condensins regulate ligand-depedent enhancer activation 0.44
RNA-seq analysis and shRNA screen of breast cancer 0.43
RNA-seq analysis of breast cancer 0.43
Gene expression profiling in metabolically heterogeneous human lung tumors 0.43
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 0.41
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.4
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.4
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.38
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.36
Gene expression alterations of pancreatic intraepithlial neoplasia 0.36
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 0.36
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 0.36
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 0.35
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.35
SNHG5 siRNA knock down in HCT116 cells 0.34
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.32
Entrectinib Resistance in a Neuroblastoma Xenograft Model 0.31
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.31
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 0.3
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 0.29
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 0.28
Human Tfh cell RNA bulk sequencing 0.26
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.26
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.26
CD86 regulates a pro-survival signal in myeloma cells 0.25
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 0.25
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.24
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.23
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.23
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.22
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 0.19
High-resolution comparative analysis of great ape genomes 0.17
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.17
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.17
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.15
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.14
RNAseq analysis of ruxolitinib treated breast cancers 0.12
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.12
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.11
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 0.1
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 0.09
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 0.09
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 0.08
Gene expression analysis of human hepatocellular cancers 0.08
Gene expression profile of human placenta from T. Cruzi infected mothers 0.07
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.06
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 0.05
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 0.05
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 0.04
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.03
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.03
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.02
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.02
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.01
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.0
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation